Drug recall · June 29, 2022
Clonazepam Orally Disintegrating Tablets recall
Why: Failed Tablet/Capsule Specification; oversized tablet found in a bottle
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clonazepam Orally Disintegrating Tablets, USP, 0.125mg, Rx Only, 60 Tablets, Mfd. by: Sun Pharmaceutical Industries Ltd. Mumbai, India, Dist. by: Sun Pharmaceutical Industries In., Cranbury, NJ 08512, NDC 57664-783-68, packaged in bottles.
- Lots / codes
Lot #: MHC1430A, Exp. Date 09/2023
- Quantity
- 4608 bottles
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- nationwide within the United States
- Initiated
- June 3, 2022 · Voluntary: Firm initiated
- Classified
- June 22, 2022
- Reported
- June 29, 2022
- Ended
- August 18, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.